This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Davies LM, Lewis S, Jones PB, Barnes TRE, Gaughran F, Hayhurst K, Markwick A, Lloyd H, CUtLASS team.Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy. British Journal of Psychiatry 191: 14-22, Jul 2007
Rights and permissions
About this article
Cite this article
Typical antipsychotics of greater benefit than atypicals. Pharmacoecon. Outcomes News 535, 7 (2007). https://doi.org/10.2165/00151234-200705350-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705350-00015